Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

PharmaGap Inc V.GAP

Healthcare Biotechnology


TSXV:GAP - Post by User

PharmaGap Inc
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(0)
•••
Post by 2udadon Jan 28, 2011 10:56pm
396 Views
Post# 18044226

ImClone

ImCloneThought I would post this article on ImClone. It was around the beginning of 2008 that I heard about Pharmagap. ImClone was in the news at that time with the cancer drug Erbitux. Kind of a legacy of Martha Steward. The drug wasn't developed over night.

https://money.cnn.com/2008/01/07/news/companies/imclone/index.htm

The drug was eventually approved and bought out by Lilly for $70 a share.

https://www.bloomberg.com/apps/news?pid=newsarchive&sid=ancTKNA.IbwA&refer=us
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities